Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
18.22B | 17.51B | 16.79B | 15.85B | 14.15B | 16.12B | Gross Profit |
7.71B | 7.13B | 6.45B | 5.50B | 4.28B | 5.13B | EBIT |
1.45B | 1.25B | 967.00M | 541.00M | -564.00M | -597.00M | EBITDA |
1.74B | 1.59B | 1.24B | 753.00M | -752.00M | -79.00M | Net Income Common Stockholders |
1.56B | 764.00M | 878.00M | 773.00M | -1.20B | -1.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
11.67B | 9.51B | 10.35B | 8.78B | 8.30B | 7.47B | Total Assets |
30.03B | 28.70B | 27.32B | 26.67B | 25.22B | 26.87B | Total Debt |
0.00 | 66.00M | 95.00M | 13.00M | 34.00M | 55.00M | Net Debt |
-11.67B | -9.51B | -10.25B | -8.76B | -8.27B | -7.42B | Total Liabilities |
5.27B | 5.15B | 4.91B | 5.43B | 4.96B | 5.76B | Stockholders Equity |
23.86B | 22.67B | 21.58B | 20.45B | 19.51B | 20.39B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.09B | 784.00M | 343.00M | 77.00M | -1.55B | Operating Cash Flow |
0.00 | 1.09B | 1.16B | 671.00M | 312.00M | -193.00M | Investing Cash Flow |
0.00 | -1.77B | 540.00M | -191.00M | 691.00M | -157.00M | Financing Cash Flow |
0.00 | -454.00M | -266.00M | -214.00M | -252.00M | -227.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $900.36B | 16.83 | 11.39% | 1.67% | 4.49% | -33.80% | |
74 Outperform | ¥12.17B | 8.94 | 2.87% | 6.17% | 67.31% | ||
73 Outperform | ¥370.41B | 14.27 | 15.34% | 2.88% | 12.32% | 41.53% | |
68 Neutral | ¥927.08B | 20.85 | 4.42% | 2.31% | 7.96% | -25.19% | |
64 Neutral | $4.39B | 12.06 | 5.17% | 249.63% | 4.03% | -11.04% | |
57 Neutral | $448.09B | 80.26 | 0.91% | 3.37% | 0.01% | -54.41% | |
57 Neutral | $242.32B | 30.20 | 3.45% | 4.18% | -0.23% | -42.21% |